Ir para o conteúdo principal

Helius Medical Technologies (NASDAQ: HSDT) — Perfil da empresa, notícias e dados financeiros

Logo de Helius Medical Technologies
HSDT Helius Medical Technologies
Helius Medical Technologies  primary media
Perfil da empresa

Helius Medical Technologies

Helius Medical Technologies (NASDAQ:HSDT) is a medical technology company focused on developing, licensing, and acquiring innovative medical products designed to amplify the brain's ability to heal itself. The company is primarily known for its pioneering work in neuromodulation, aiming to provide new solutions for patients suffering from neurological symptoms caused by disease or trauma. At the core of its operations is the development of its flagship product, the Portable Neuromodulation Stimulator (PoNS™) device, which represents a groundbreaking approach in non-invasive neurotherapy for the treatment of neurological symptoms. Helius Medical Technologies is passionately committed to improving patient outcomes and advancing neuroscientific understanding, striving to expand its portfolio through ongoing research and strategic collaborations.

Resumo

Public USParticipação acionária
2014Ano de fundação
26Funcionários
Pennsylvania, United StatesSede
Carregando mapa...
Presença global

Operações

Todos os locais
United States

Produtos e/ou serviços de Helius Medical Technologies

  • Portable Neuromodulation Stimulator (PoNS) device - A non-invasive medical device designed for neurorehabilitation to improve gait and balance in patients with neurological symptoms.
  • PoNS Treatment - A comprehensive therapy program that combines physical therapy with the PoNS device to enhance neuroplasticity and rehabilitate neurological functions.
  • Clinical Trials - Conducting rigorous clinical studies to evaluate the efficacy and safety of the PoNS device in treating various neurological conditions.
  • Research and Development - Ongoing investment in R&D to innovate and improve neurostimulation technologies for neurological disorders rehabilitation.
  • Regulatory Approvals - Securing regulatory clearances worldwide, including FDA authorization in the United States, for the PoNS device.
  • Partnerships and Collaborations - Establishing strategic partnerships to expand the reach and accessibility of their neurorehabilitation solutions.

equipe executiva do Helius Medical Technologies

  • Choon Wee CheeCEO, President & Chairman
  • Agustina Gani TjandrasuwitaCOO, CFO, Treasurer & Secretary

Últimas notícias sobre a Helius Medical Technologies

Principais indicadores financeiros

Resultados divulgados pela Helius Medical Technologies , em USD.

Cap. de mercado
149,1 mi
Receita (TTM)
12,1 mi
P/L
0.0
LPA (diluído, TTM)
53.7
Dividend yield
—
Margem de lucro
0.0%
Receita e lucro anuais da Helius Medical Technologies
Fim do ano fiscalReceitaResultado operacionalLucro líquido
6 mi-21,1 mi-40,9 mi
520 mil-13,9 mi-11,7 mi
644 mil-12,4 mi-8,9 mi
787 mil-15,5 mi-14,1 mi